Chip export controls not discussed at US-China meeting– Greer tells Bloomberg

U.S.-China talks did not materially advance chip export controls, but Reuters reported Nvidia’s H200 AI chip was approved for sale to 10 Chinese companies, with no sales yet made. The article also highlights expectations for larger U.S. agricultural purchases from China and continued soybean commitments. Nvidia CEO Jensen Huang’s presence alongside Trump, Musk, and Cook underscores ongoing policy sensitivity around AI chip access to China.

Analysis

The market implication is not that export controls are disappearing, but that enforcement is likely shifting from a blanket choke point to a more selective, transaction-by-transaction regime. That is constructive for NVDA because even modest re-openings of China access can add meaningful incremental revenue without requiring a full policy reversal; the second-order effect is that supply chain capacity, not just policy, becomes the binding constraint if orders re-accelerate. The immediate beneficiary is NVDA, while domestic China AI chip vendors face a tougher competitive bar if high-end U.S. silicon becomes intermittently available again.

The bigger read-through is to Tesla and Apple sentiment, but for different reasons than headline optics. Tesla benefits only indirectly: improved U.S.-China dialogue lowers the probability of a punitive tech-trade spiral that would have hit China EV demand and consumer confidence, but it does little for near-term fundamentals. Apple is the more interesting second-order beneficiary because easing geopolitical tension reduces the odds of asymmetric retaliation against a premium U.S. consumer hardware brand with a large China footprint.

The key risk is that this remains highly reversible: one adverse comment on Taiwan, semiconductor leakage, or a failed negotiation could re-tighten the policy overhang within days. Over a 1-3 month horizon, the trade is less about actual H200 shipment volume and more about expectations of future rule relaxation, which can drive multiple expansion before revenue shows up. If China starts buying at scale, the upside for NVDA is real; if approvals stay symbolic, the stock may give back gains once the market realizes revenue contribution is delayed.

Consensus may be underestimating how bullish even partial ambiguity is for semi multiples. Investors are positioned for either complete restriction or complete détente, but the more likely path is a messy middle that preserves optionality for the biggest U.S. AI platform names while keeping Chinese competition constrained enough to avoid immediate share loss. That dynamic favors NVDA on a relative basis over equipment names and over China-exposed hardware suppliers that need clean policy clarity to de-risk forecasts.

Key Decisions for Investors

• Add NVDA on any pullback tied to policy headlines over the next 1-2 weeks; favor upside optionality via call spreads rather than outright stock given binary reversal risk.
• Buy a 1-3 month NVDA / short China AI hardware basket pair trade if available; the thesis is that even modest export relaxation extends NVDA’s moat while Chinese local competitors face uncertainty on performance parity.
• Maintain a tactical long AAPL into any easing rhetoric around U.S.-China ties for the next 4-8 weeks; the setup is sentiment-driven with lower fundamental sensitivity than semis, so use tight stops.
• Avoid chasing TSLA on the headline unless there is evidence of a broader bilateral thaw; the benefit is mostly indirect and likely to lag by quarters, not weeks.
• Use NVDA implied volatility to structure upside exposure after policy-driven dips; risk/reward is favorable because the market is pricing a low-probability policy inflection that could re-rate the stock quickly.